Clinical Validation of the Abbott RealTime High Risk HPV Assay According to the Guidelines for Human Papillomavirus DNA Test Requirements for Cervical Screening

Ítems similars

• The Aptima HPV Assay Fulfills the Cross-Sectional Clinical and Reproducibility Criteria of International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
  per: Heideman, D. A. M., et al.
  Publicat: (2013)
• Clinical Validation of the HPV-Risk Assay, a Novel Real-Time PCR Assay for Detection of High-Risk Human Papillomavirus DNA by Targeting the E7 Region
  per: Hesselink, A. T., et al.
  Publicat: (2014)
• Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes
  per: Heideman, D. A. M., et al.
  Publicat: (2011)
• Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 Assays to Direct Sequencing and Genotyping of HPV DNA
  per: Park, Yongjung, et al.
  Publicat: (2012)
• Comparison of the Clinical Performance of PapilloCheck Human Papillomavirus Detection with That of the GP5+/6+-PCR-Enzyme Immunoassay in Population-Based Cervical Screening
  per: Hesselink, A. T., et al.
  Publicat: (2010)